Medical Marijuana HIV/AIDS Research Articles
Cannabinoid Administration Halts Disease Progression, Decreases Mortality In Primate Version of Human Immunodeficiency Virus (HIV)
June 14th, 2011 By: Paul Armentano, NORML Deputy Director The long-term administration of delta-9-THC, the primary psychoactive compound in marijuana, is associated with decreased mortality in monkeys infected with the simian immunodeficiency virus (SIV), a primate...
Cannabinoid receptors give cells the tools they need to defend against HIV infection
Researchers have reported that when healthy cells were placed in a sample dish with the human immunodeficiency virus (HIV), along with a dose of cannabinoids, the cells, which normally would rather quickly become infected, simply denied entry to the virus, and responded as if it were not a threat at all.